Complete the form below to submit an RFP. Companies needing our Confidentiality Disclosure Agreement may request it here.
- New Approaches for the Value Assessment of Advanced Medical Products
- VeraSci Partners with Boehringer Ingelheim on Innovative Phase III Program for Breakthrough Therapy in Cognitive Impairment Associated with Schizophrenia
- Recent Innovations and their Regulatory Implications for Multiple Sclerosis Trials Addressed in a Special Issue of the Journal of Clinical Neurophysiology by VeraSci Experts